Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion type Assertion NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_head.
- NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion description "[Our results support the hypothesis that the EGFR/B-Raf(V600E) dual inhibition might be a tractable strategy to overcome the intrinsic and acquired resistance of melanoma and/or colorectal cancers against the current B-Raf(V600E) inhibitor therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_provenance.
- NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion evidence source_evidence_literature NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_provenance.
- NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion SIO_000772 24588073 NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_provenance.
- NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion wasDerivedFrom befree-20150227 NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_provenance.
- NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_assertion wasGeneratedBy ECO_0000203 NP368817.RAWh8u84W4gfTAMvRuyGCe8LZnD4z3pJiiHyTl6VpFFpU130_provenance.